title: Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study.
abstract: A pedigree of a large family with high prevalence of heart disease is subjected to association and sib-pair linkage analysis to investigate the role of 5 candidate genes in the regulation of lipoprotein metabolism and the development of coronary artery disease. At the 5% nominal significance level, the apolipoprotein B locus (APOB) was found to be linked to high-density lipoprotein cholesterol level (HDL-C), low-density lipoprotein cholesterol level (LDL-C), the ratio HDL-C/LDL-C, and apolipoprotein AI level times this ratio (apoAI x LDL-C/HDL-C). APOB (PvuII) was strongly associated with apolipoprotein B levels (apoB) (P = 0.006) and the VNTR region of the APOB locus showed highly significant association between allele 7 and low triglyceride levels (P = 0.004). No significant linkage results were found with cholesterol ester transfer protein (CETP). At the 1% nominal significance level, CETP [TaqI(B)] showed significant association with LDL-C, apoB, and HDL-C/LDL-C. There was significant linkage of lipoprotein lipase (LPL) with very-low-density lipoprotein cholesterol and the ratio apoAI/HDL-C, and strong association results between LPL (HindIII) and triglyceride levels (P = 0.005). At the 5% nominal significance level, haptoglobin (HPA) was associated with HDL-C, HDL-C/LDL-C, apoAI/HDL-C and apoAI x LDL-C/HDL-C. The apolipoprotein AI locus did not show any significant linkages or associations. The study thus indicated that genetic variation of APOB, LPL, CETP, and lecithin cholesterol acyl transferase (which is linked to HPA and CETP) may play an important role in the regulation of lipoprotein metabolism and could contribute to the risk of coronary artery disease.
authors.affiliation: Department of Biometry and Genetics, LSU Medical Center, New Orleans 70112-1393.
authors.forename: I M
authors.initials: IM
authors.lastname: Heiba
authors.forename: C A
authors.initials: CA
authors.lastname: DeMeester
authors.forename: Y R
authors.initials: YR
authors.lastname: Xia
authors.forename: A
authors.initials: A
authors.lastname: Diep
authors.forename: V T
authors.initials: VT
authors.lastname: George
authors.forename: C I
authors.initials: CI
authors.lastname: Amos
authors.forename: S R
authors.initials: SR
authors.lastname: Srinivasan
authors.forename: G S
authors.initials: GS
authors.lastname: Berenson
authors.forename: R C
authors.initials: RC
authors.lastname: Elston
authors.forename: A J
authors.initials: AJ
authors.lastname: Lusis
mesh_terms: D001053:Apolipoproteins / Q000032:analysis / Q000235:genetics; D001055:Apolipoproteins B / Q000032:analysis / Q000235:genetics; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000235:genetics*; D008040:Genetic Linkage; D005838:Genotype; D006801:Humans; D008074:Lipoproteins / Q000097:blood* / Q000235:genetics; D008145:Louisiana; D009679:Nuclear Family; D010375:Pedigree; D010641:Phenotype; D014280:Triglycerides / Q000097:blood
chemical_list: D001053:Apolipoproteins; D001055:Apolipoproteins B; D008074:Lipoproteins; D014280:Triglycerides; D002784:Cholesterol